Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
D. Gudipudi
Observed name:
Duleep Gudipudi
Institution:
Basavatarakam Indo American Cancer Hospital and Research Institute
Observed institution:
Basavatarakam Indo American Cancer Hospital and Research Institute
ORCID:
0000-0003-3447-4725
Observed ORCID:
0000-0003-3447-4725
OpenAlex ID:
A5049647374
Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase III Multicenter Randomized Controlled Trial
2024
·
Vedang Murthy
, Priyamvada Maitre
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
17
Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer
2023
·
V. Murthy
, P. Maitre
, et al.
·
Clinical Oncology
·
9
PDF
Comparing artificial intelligence and multidisciplinary tumor board decision making in real-world cancer care: a prospective blinded concordance study
2026
·
R. Pinninti
, R. Gullapalli
, et al.
·
ESMO Real World Data and Digital Oncology
·
7
PDF
Bladder Adjuvant RadioTherapy (BART): Clinical Outcomes from a Phase III Multicenter Randomized Controlled Trial
2025
·
V. Murthy
, P. Maitre
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
5
PDF
From exclusion to inclusion: Analysis of patterns of follow-up in breast cancer
2025
·
N. Hariharan
, T. S. Rao
, et al.
·
International Journal of Surgery Protocols
·
1
Bladder Adjuvant RadioTherapy (BART): Acute and Late Toxicity from a Phase III Multicenter Randomized Controlled Trial
2024
·
V. Murthy
, P. Maitre
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
PDF
Show more works
View as search
Works count:
6
Citation count:
40
H-index:
4
I10-index:
1
Year
Topic
Type